ClinicalTrials.gov
public full text
Public Domain
Tenecteplase Versus Alteplase in Ischemic Stroke Management (TALISMAN)
This is a double-blind parallel arm randomized trial aimed to assess efficacy and safety of intravenous Tenecteplase compared to intravenous Alteplase in eligible patients who present with symptoms of acute ischemic stroke within 3 to 4.5 hours from onset.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Tenecteplase versus alteplase for patients with minor acute ischemic stroke: an analysis of the ORIGINAL clinical trial#29759
- Alteplase-Tenecteplase Trial Evaluation for Stroke Thrombolysis- (ATTEST)#807170
- CHinese Acute Tissue-Based Imaging Selection for Lysis In Stroke -Tenecteplase II#1093974
- Intravenous Tenecteplase in Very Old Patients With Acute Ischemic Stroke#853674
- Tenecteplase in Stroke Patients Between 4.5 and 24 Hours#890154
Record · ID 1375441
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive